LHDXQ Insider Trading
Insider Ownership Percentage: 30.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Lucira Health Share Price & Price History
Current Price: $0.00
Price Change: ▲ Price Increase of +0.0001 (∞)
As of 10/4/2023 10:04 PM ET
Lucira Health Insider Trading History
Lucira Health Institutional Trading History
Data available starting January 2016
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Read More on Lucira Health
Volume
20,900 shs
Average Volume
7,181,606 shs
Market Capitalization
$4.06 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.6